Scandinavian ChemoTech AB engages in the development of extensive cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2016-12-06. The firm is focused on cancer treatment and manufactures specialized medical equipment. The firm's product IQWave is an electrochemotherapy (ECT) device. The IQWave system enhances the effects of the chemotherapeutic substance by opening up small pores in the tumor cells, giving the injected chemotherapeutic substance (no more than 15 IU of bleomycin) direct access to the DNA of the target cells. Among the product's applications are hypernephroma, kaposi sarcoma, transitional cell carcinoma, head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma. The treatment can be used for cutaneous as well as subcutaneous tumors.

8V6.F Profile, Market Tickers and Other

8V6.F profile

8V6.F market tickers